These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38425290)
1. Breast Milk Excretion of Dinalbuphine Sebacate Injection Administered After Cesarean Section. Tang SL; Wang KY; Hsiao WK; Lin CK J Clin Pharmacol; 2024 Jun; 64(6):755-761. PubMed ID: 38425290 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of dinalbuphine sebacate and nalbuphine in human after intramuscular injection of dinalbuphine sebacate in an extended-release formulation. Tien YE; Huang WC; Kuo HY; Tai L; Uang YS; Chern WH; Huang JD Biopharm Drug Dispos; 2017 Nov; 38(8):494-497. PubMed ID: 28741675 [TBL] [Abstract][Full Text] [Related]
3. Multimodal Analgesia With Extended-Release Dinalbuphine Sebacate for Perioperative Management: Expert Opinion and Consensus. Lee SO; Lu CH; Man KM; Cheng KI; Wong CS; Sun WZ Asian J Anesthesiol; 2023 Sep; 61(3):123-131. PubMed ID: 38320858 [TBL] [Abstract][Full Text] [Related]
4. [Elimination of nalbuphine in human milk]. Wischnik A; Wetzelsberger N; Lücker PW Arzneimittelforschung; 1988 Oct; 38(10):1496-8. PubMed ID: 3196391 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo release of dinalbuphine sebacate extended release formulation: Effect of the oil ratio on drug release. Li CJ; Ku MY; Lu CY; Tien YE; Chern WH; Huang JD Int J Pharm; 2017 Oct; 531(1):306-312. PubMed ID: 28847670 [TBL] [Abstract][Full Text] [Related]
6. Sebacoyl Dinalbuphine Ester Extended-release Injection for Long-acting Analgesia: A Multicenter, Randomized, Double-Blind, And Placebo-controlled Study in Hemorrhoidectomy Patients. Yeh CY; Jao SW; Chen JS; Fan CW; Chen HH; Hsieh PS; Wu CC; Lee CC; Kuo YH; Hsieh MC; Huang WS; Chung YC; Liou TY; Chiu HH; Tseng WK; Lee KC; Wang JY Clin J Pain; 2017 May; 33(5):429-434. PubMed ID: 27518486 [TBL] [Abstract][Full Text] [Related]
7. Excretion of ketoprofen and nalbuphine in human milk during treatment of maternal pain after delivery. Jacqz-Aigrain E; Serreau R; Boissinot C; Popon M; Sobel A; Michel J; Sibony O Ther Drug Monit; 2007 Dec; 29(6):815-8. PubMed ID: 18043481 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of an extended-release sebacoyl dinalbuphine ester for laparoscopic cholecystectomy: A randomized controlled trial. Lee YE; Fu CY; Shiue YL; Lu CY; Chen CY; Chen JH; Chen JL; Lam CF Medicine (Baltimore); 2023 Aug; 102(31):e34423. PubMed ID: 37543779 [TBL] [Abstract][Full Text] [Related]
9. Comparing efficacy and safety between Naldebain Tsai HL; Chang TK; Su WC; Yeh YS; Huang CW; Ma CJ; Wang JY Trials; 2019 Mar; 20(1):173. PubMed ID: 30885242 [TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind study to compare the efficacy and safety of nalbuphine nasal spray and injectable solution in patients after orthopaedic interventions and traumatological procedures. Tymko VG; Tsapko GV; Filipenko VA; Khvysiuk OM; Kovalova KV; Kuznetsov IE Br J Clin Pharmacol; 2024 Jul; 90(7):1728-1740. PubMed ID: 38649145 [TBL] [Abstract][Full Text] [Related]
11. Oxycodone as a component of multimodal analgesia for lactating mothers after Caesarean section: relationships between maternal plasma, breast milk and neonatal plasma levels. Seaton S; Reeves M; McLean S Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):181-5. PubMed ID: 17550483 [TBL] [Abstract][Full Text] [Related]
12. Advantages of intrathecal nalbuphine, compared with intrathecal morphine, after cesarean delivery: an evaluation of postoperative analgesia and adverse effects. Culebras X; Gaggero G; Zatloukal J; Kern C; Marti RA Anesth Analg; 2000 Sep; 91(3):601-5. PubMed ID: 10960384 [TBL] [Abstract][Full Text] [Related]
13. Amphiphilic NLC-Gel formulation loaded with Sebacoyl dinalbuphine ester and Nalbuphine for localized postoperative pain management. Lin CL; Li YL; Chen YW; Kuo CH; Tu TY; Liu YF; Tsai JC; Shyong YJ Int J Pharm; 2024 Jun; 659():124295. PubMed ID: 38823469 [TBL] [Abstract][Full Text] [Related]
14. Excretion of ketobemidone in human breast milk. Gerdin E; Bondesson U; Hartvig P J Perinat Med; 1996; 24(3):293-5. PubMed ID: 8827580 [TBL] [Abstract][Full Text] [Related]
15. Preoperative Administration of Extended-Release Dinalbuphine Sebacate Compares with Morphine for Post-Laparoscopic Cholecystectomy Pain Management: A Randomized Study. Lee SO; Huang LP; Wong CS J Pain Res; 2020; 13():2247-2253. PubMed ID: 32982387 [TBL] [Abstract][Full Text] [Related]
16. Multimodal Analgesia with Extended-Release Dinalbuphine Sebacate for Perioperative Pain Management in Upper Extremity Trauma Surgery: A Retrospective Comparative Study. Zheng ZH; Yeh TT; Yeh CC; Lin PA; Wong CS; Lee PY; Lu CH Pain Ther; 2022 Jun; 11(2):643-653. PubMed ID: 35426567 [TBL] [Abstract][Full Text] [Related]
17. Extended-Release Dinalbuphine Sebacate Versus Intravenous Patient-Controlled Analgesia with Fentanyl for Postoperative Moderate-to-Severe Pain: A Randomized Controlled Trial. Chang TK; Huang CW; Su WC; Tsai HL; Ma CJ; Yeh YS; Chen YC; Li CC; Cheng KI; Su MP; Wang JY Pain Ther; 2020 Dec; 9(2):671-681. PubMed ID: 32990938 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic comparison of nalbuphine with single injection and patient-controlled analgesia mimic method in healthy Chinese volunteers. He K; Ji W; Zhao H; Wei Y; Yang S; Wen Q J Clin Pharm Ther; 2021 Aug; 46(4):1166-1172. PubMed ID: 33942343 [TBL] [Abstract][Full Text] [Related]
19. Intrathecal nalbuphine after cesarean delivery: are we ready? Yaksh T; Birnbach DJ Anesth Analg; 2000 Sep; 91(3):505-8. PubMed ID: 10960366 [No Abstract] [Full Text] [Related]